Peter W. Horby

Peter W. Horby

University of Oxford

H-index: 89

Europe-United Kingdom

About Peter W. Horby

Peter W. Horby, With an exceptional h-index of 89 and a recent h-index of 72 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Clinical research, emerging infectious diseases, epidemic infectious diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Nipah virus disease: what can we do to improve patient care?

Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials

Involve those, who are managing these outbreaks Identifying barriers and facilitators to the implementation of clinical management guidelines for High-Consequence Infectious …

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Cohort profile: a multicenter European study of acute respiratory infections: the MERMAIDS-ARI 2.0 cohort study

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Mpox: The alarm went off. Have we gone back to sleep?

Natural immune boosting can cause synchrony in susceptibility and outbreaks of respiratory infections with rapidly waning immunity

Peter W. Horby Information

University

Position

Professor of Emerging Infectious Diseases

Citations(all)

70890

Citations(since 2020)

61526

Cited By

29440

hIndex(all)

89

hIndex(since 2020)

72

i10Index(all)

245

i10Index(since 2020)

208

Email

University Profile Page

University of Oxford

Google Scholar

View Google Scholar Profile

Peter W. Horby Skills & Research Interests

Clinical research

emerging infectious diseases

epidemic infectious diseases

Top articles of Peter W. Horby

Title

Journal

Author(s)

Publication Date

Nipah virus disease: what can we do to improve patient care?

Md Zakiul Hassan

Tahmina Shirin

Syed M Satter

Mohammed Z Rahman

Josephine Bourner

...

2024/1/4

Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials

Xin Hui S Chan

Ilsa L Haeusler

Bennett JK Choy

Md Zakiul Hassan

Junko Takata

...

2024

Involve those, who are managing these outbreaks Identifying barriers and facilitators to the implementation of clinical management guidelines for High-Consequence Infectious …

medRxiv

Olive Kabajaasi

Stefan Schilling

Mathias Akugizibwe

Peter Horby

Peter Hart

...

2024

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

The Lancet Child & Adolescent Health

Saul N Faust

Richard Haynes

Christine E Jones

Natalie Staplin

Elizabeth Whittaker

...

2024/3/1

Cohort profile: a multicenter European study of acute respiratory infections: the MERMAIDS-ARI 2.0 cohort study

medRxiv

Marieke de Hoog

Cristina Prat-Aymerich

Darren Troeman

James Lee

Greet Ieven

...

2024

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Nature Communications

Peter Sandercock

Janet Darbyshire

David DeMets

Robert Fowler

David Lalloo

...

2024/1/31

Mpox: The alarm went off. Have we gone back to sleep?

PLOS Neglected Tropical Diseases

Piero Olliaro

Josephine Bourner

Yap Boum II

Emmanuel Nakouné

Elise Pesonel

...

2024/1/18

Natural immune boosting can cause synchrony in susceptibility and outbreaks of respiratory infections with rapidly waning immunity

medRxiv

Mark G Pritchard

Sean M Cavany

Susanna J Dunachie

Graham F Medley

Lance Turtle

...

2023

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study

PLoS Neglected Tropical Diseases

Nzelle Delphine Kayem

Sylvanus Okogbenin

Joseph Okoeguale

Joseph Eigbefoh

Joseph Ikheloa

...

2023/4/13

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low-and middle-income …

Research and practice in thrombosis and haemostasis

Matthew J Griffee

Patricia T Bozza

Luis Felipe Reyes

Devin P Eddington

Dorothea Rosenberger

...

2023/7/1

The burden and dynamics of hospital-acquired SARS-CoV-2 in England

Nature

Ben S Cooper

Stephanie Evans

Yalda Jafari

Thi Mui Pham

Yin Mo

...

2023/11/2

Community involvement in an outbreak—one year on for mpox

Clinical Infectious Diseases

Ashleigh Cheyne

Ian Muchamore

Harun Tulunay

Amanda Rojek

Leon Peto

...

2023/12/7

Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 …

The Lancet Child & Adolescent Health

Saul N Faust

Christine E Jones

Natalie Staplin

Elizabeth Whittaker

Thomas Jaki

...

2023

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

International journal of epidemiology

Christiana Kartsonaki

J Kenneth Baillie

Noelia García Barrio

Joaquín Baruch

Abigail Beane

...

2023/4/1

Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs

Ishmeala Rigby

Melina Michelen

Andrew Dagens

Vincent Cheng

Dania Dahmash

...

2023/7/1

International pediatric COVID-19 severity over the course of the pandemic

JAMA pediatrics

Yanshan Zhu

Flávia Jacqueline Almeida

J Kenneth Baillie

Asha C Bowen

Philip N Britton

...

2023/10/1

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19

JAMA Network Open

Félix Camirand-Lemyre

Laura Merson

Bharath Kumar Tirupakuzhi Vijayaraghavan

Aidan JC Burrell

Barbara Wanjiru Citarella

...

2023/12/1

MOSAIC: A cohort study of human mpox virus disease

Wellcome Open Research

Elise Pesonel

Isabelle Hoffmann

Laetitia Guiraud

Josephine Bourner

Alpha Diallo

...

2023

Randomised controlled trials for mpox in endemic countries

The Lancet Infectious Diseases

Amanda Rojek

Jake Dunning

Richard Haynes

Peter Horby

Leon Peto

2023/3/1

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Nature

Erola Pairo-Castineira

Konrad Rawlik

Andrew D Bretherick

Ting Qi

Yang Wu

...

2023/5/25

See List of Professors in Peter W. Horby University(University of Oxford)

Co-Authors

H-index: 77
Malcolm G Semple

Malcolm G Semple

University of Liverpool

H-index: 69
Heiman Wertheim

Heiman Wertheim

Radboud Universiteit

H-index: 55
Jake Dunning

Jake Dunning

University of Oxford

H-index: 18
Amanda Rojek

Amanda Rojek

University of Oxford

academic-engine